Enterprise virtual reality (VR) software provider Immerse has today announced its new partnership with DTG, a digital transformation company that delivers technology and solutions that enable clients to embrace the operational, cultural and financial benefits of digitalisation.
The award win recognizes Nanoform as a listed company that places innovation at the center of its strategy for business development and introduces an innovative technology to the market.
Nanoform, an innovative nanoparticle medicine enabling company, today announced it has received ISO/IEC 27001:2013 certification for its Information Security Management System (ISMS).
This issue includes news, contributions and comment on key industry issues from major opinion leaders in the life sciences sector, as well as an overview of the inaugural PharmaTech Integrates conference which took place on 23 September.
With over 80 speakers, 19 sponsors, and 500 attendees, the event provided unique opportunities for the sharing of ideas between leaders and innovators via panel discussions, showcases, interviews, and networking.
Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc (“Herantis”), focusing on disease modifying therapies for debilitating neurodegenerative diseases based on the natural body protein CDNF (Cerebral Dopamine Neurotrophic Factor), today announced that results from the Nanoform Proof of Concept (PoC) project show that the nanoforming process has been successfully applied to Herantis’ rhCDNF drug candidate.